Recent Updates
Recently added Catalysts

Nurofen Plus

Phase 3

Post-operative Pain | Small molecule | Other |Catalent, Inc.|Last Updated: Sep 17, 2018

Development status

Highest phase Phase 3
Registered trials 1 across 1 sponsor since Oct 2010

Success Probability

Subscribe to view

Market & Valuation

Subscribe to view

Trial Design

RandomizedDouble-BlindPLACEBO_CONTROLLED
Total Trials1
Total Enrollment678

FDA Designations

No designations recorded

Clinical trial landscape

Nurofen Plus · 1 trial · 1 indication

Phase 3 1
NCT01229449Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain StudyPost-operative Pain
COMPLETED678 Analytics
PHASE3COMPLETED
Ibuprofen/Acetaminophen Versus Nurofen Plus® and Panadeine® Extra Dental Pain Study
Post-operative PainUnlock trial analytics

Study Endpoints

Primary Endpoints

Change From Baseline in Area Under the Curve (AUC) of Pain Intensity and Relief Scores (SPRID)
0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11 and 12 hours post-dose

SPRID 0-12h: Sum of pain intensity difference (PID) and the pain relief (PR) score over the twelve-hour follow-up period. Score range: 0mm = No pain and 100mm = Worst pain. This was calculated as the area under the curve (AUC) using the method of linear trapezoids assuming that the baseline assessment took place at time zero. Pain intensity (PI) was measured by pain assessment questionnaire, where subject tick the appropriate box in a 4-point ordinal scale ranging from 0 = No pain, 1 = Mild pain, 2 = Moderate pain, and 3 = Severe pain, in response to the question 'What is your pain level at this time?' Total Pain Relief (TOTPAR) was measured using pain assessment diary, where subject tick the appropriate box on a 5-point Ordinal Rating Scale: 0 = None, 1 = A Little, 2 = Some, 3 = A Lot, and 4 = Complete, in response to the question 'How much relief have you had from your starting pain?'

Secondary Endpoints

Change From Baseline in AUC (0-8h) of SPRID
0 (baseline), 0.25, 0.5, 0.75, 1, 1.5, 2, 3, 4, 5, 6, 7, and 8 hours post-dose
Change From Baseline in AUC for Pain Intensity Difference Scores (SPID)
0-4, 0-6, 0-8 and 0-12 hours
Change From Baseline in AUC of Pain Relief Scores (TOTPAR)
0-4, 0-6, 0-8 and 0-12 hours
Unlock Study Endpoints

Study Design & Arms

AllocationRANDOMIZED
MaskingQUADRUPLE
ModelPARALLEL
PurposeTREATMENT

Treatment Arms

ArmTypeDescription
Ibuprofen/acetaminophen (lower dose)EXPERIMENTALOne tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet
Ibuprofen/acetaminophen (higher dose)EXPERIMENTALTwo tablets of ibuprofen 200 mg plus acetaminophen 500 mg
Nurofen Plus®ACTIVE_COMPARATORTwo tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®)
Panadeine® ExtraACTIVE_COMPARATORTwo tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra)
PlaceboPLACEBO_COMPARATORTwo placebo tablets

Interventions

NameTypeDescription
Ibuprofen/acetaminophenDRUGOne tablet of ibuprofen 200 mg plus acetaminophen 500 mg and one placebo tablet, single dose taken orally with 300 ml water
Ibuprofen/acetaminophen (higher dose)DRUGTwo tablets of ibuprofen 200 mg plus acetaminophen 500 mg, single dose taken orally with 300 ml water
Nurofen Plus®DRUGTwo tablets ibuprofen 200mg plus codeine 12.8mg (Nurofen Plus®), single dose taken orally with 300 ml water
Panadeine® ExtraDRUGTwo tablets acetaminophen 500 mg plus codeine 15 mg (Panadeine® Extra), single dose taken orally with 300 ml water
PlaceboDRUGTwo placebo tablets, single dose taken orally with 300 ml water
Unlock Study Design Details

Eligibility Criteria

Age Range16 Years to N/A
SexALL
Healthy VolunteersNo
Study Sites1

Main Inclusion Criteria: Experiencing moderate to severe pain after extraction of impacted third molars Main Exclusion Criteria: Any ongoing painful condition other than that associated with the current third molar surgery that could significantly interfere with the subject's suitability Any cond...

Countries:United States
Unlock Eligibility Criteria

Competitive Landscape -Surgical and Perioperative 71 trials (matched to "Post-operative Pain")

No competing companies are currently tracked in active development for Surgical and Perioperative.
Unlock Competitive Intelligence